Adamax — Deep Research (Cognitive & Nootropic)
Published · Researched 2026-09-21
Research file written 2026-09-21. Social-first methodology: community sources weighted before vendor pages.
1. Overview
Adamax is a synthetic Semax analog, not a Semax/Selank blend (a common mislisting — some vendors describe it as a blend; current vendor spec sheets identify it as an N-acetylated, adamantane-modified Semax analog). One seller gives the sequence Ac-MEHFPGPAG-NH₂ — Semax (MEHFPGP) plus a C-terminal Ala-Gly and amidation — while another describes an adamantylglycine-containing form around ~1032 Da (BehemothLabz / vendor spec tables, 2026). Identity/specification disagreement exists across vendors and must be disclosed, not resolved by guessing: buyers cannot be certain which analog identity a given "Adamax" vial corresponds to without a third-party COA matching a stated sequence.
The adamantane modification is the design story: adamantane derivatives are known in medicinal chemistry for membrane permeability and proteolytic stability, so the analog is marketed as a longer-acting, more stable Semax. It appeared on the gray market well after Semax/Selank and remains a niche SKU.
2. Social standing
A visible but de-ranked frontier hypothesis. The June-2026 GitHub hukus/llimitless category scan places Adamax below Semax/Selank/Cerebrolysin on anecdote density. A 2026 critical explainer (Medium: "American Peptides Neuro Research Explainer — Semax, Selank, Adamax, Dihexa, PE-22-28 and P-21") states Adamax's specific evidence base is much less developed than the other frontier compounds. "Silicon Valley is obsessed with Adamax" style content exists — treat as hype/marketing, not consensus.
- YouTube: a personal-comparison video (linked below) claimed longer duration, consistency, focus, and clarity than Semax — one creator's account, not evidence.
- TikTok: search snippets show Semax-vs-Adamax discussion, i.e., the compound is known in short-form creator circles.
- Threads: searches this round returned mainly generic peptide/supplier posts, not strong Adamax-specific owner evidence.
- Facebook Groups: no Adamax-specific posts surfaced this round.
- Recurring community question: whether Adamax is "Semax but longer-lasting" — vendor answer is yes; no independent controlled verification found.
- Overhyped warnings: any claim that Adamax has "human trials" or "proven superiority to Semax" is UNVERIFIED — no human trial data found.
3. Social validation — Tier 3 / UNVALIDATED — included for comparison, low community signal
- YouTube creator content (personal comparison video): proves at least one self-experimenter bought and compared it against Semax and reported longer duration/consistency. Proves minimal real-world use, not efficacy.
- TikTok search snippets (Semax-vs-Adamax discussion): proves the compound is discussed in short-form creator culture. Proves name recognition, not endorsement quality.
- 2026 critical explainer (Medium): proves analysts consider Adamax one of the named neuro-research frontier compounds — and explicitly that its evidence base lags the others.
- Vendor spec tables (BehemothLabz and others): prove multi-vendor commercial availability; also expose the identity-disagreement problem.
- Missing: no named Facebook Group posts, no Threads owner content, no forum experience threads with substance were found this round. Effectively no independent review footprint.
4. Key specs table
| Spec | Value | Source/status |
|---|---|---|
| Identity (claimed) | N-acetylated, adamantane-modified Semax analog; one spec: Ac-MEHFPGPAG-NH₂; another: adamantylglycine form ~1032 Da | Vendor spec tables — disagreement across vendors, UNVERIFIED per-vial identity |
| Molecular weight | ~1032 Da (one vendor's adamantyl form) | Vendor spec table — treat as approximate |
| Form | Lyophilized powder vials (10 mg standard); some nasal spray SKUs | Vendor listings |
| Design rationale | Adamantane for stability/membrane permeability; N-acetylation for protease resistance | Medicinal-chemistry reasoning, vendor copy |
| Human trials | None found | Community literature cross-checks |
| Route (vendor positioning) | Subcutaneous or nasal, varies by seller | Vendor listings — no protocol in any research literature |
5. Pricing (observed 2026-09-21)
| Offer | Price | Source |
|---|---|---|
| Adamax 10 mg vial | $50.00 ($30/vial in 10-pack) | High Tide, observed 2026-09-21 |
| Adamax 10 mg vial | $75.00 (first-order illustration $56.25) | SourcePeptides, observed 2026-09-21 |
| Adamax 10 mg vial | $85.00 | Protide Health, observed 2026-09-21 |
| Adamax 10 mg vial | $89.00 | LabSourced, observed 2026-09-21 |
| Adamax 10 mg vial | $115.00 | Vault, observed 2026-09-21 |
| Adamax 10 mg vial | $140.00 | Real Peptides, observed 2026-09-21 |
| 10 mg nasal spray | $75.99 | PS Peptides, observed 2026-09-21 |
| 2026 PDF price list | $300.00 — extreme outlier | Vendor PDF price list, 2026 |
Marketplace used range: not observed — report honestly, no used-market data found. The spread ($50–$140, outlier $300) is wider than the compound's evidence base justifies and suggests heavy markup variance for what is nominally the same SKU — itself a signal of the identity/quality uncertainty.
6. What's included / what's needed
- Lyophilized vial ships as powder; reconstitution solution typically sold separately.
- No established dosing protocol exists in any research literature; all dosing is community folklore, not guidance.
7. Support reality
- COA culture: claimed third-party testing is the norm on listings; per-vial identity matching a stated sequence is the only way to know which analog you actually received — and buyers rarely get it.
- Label risk (major): vendors disagree on what "Adamax" is (Semax+Selank blend vs. Ac-MEHFPGPAG-NH₂ vs. adamantylglycine form). One seller (Real Peptides) markets Adamax under "metabolic signaling" copy inconsistent with the nootropic positioning — sloppy copy that undermines confidence in vendor understanding of the product.
- Gray-market risk: research-use-only labeling everywhere; no pharmacy QA chain.
8. Community verdict
Adamax is a frontier SKU riding Semax's reputation with thinner evidence, thinner discussion, and a vendor identity problem — sellers don't agree on what molecule they're selling. The few community voices describe it as "Semax but longer-lasting," but there is no human data to check that against, and the price spread ($50–$140 for the same 10 mg) reflects markup chaos more than quality tiers. The honest consensus: interesting design story, UNVALIDATED molecule, buy-with-caution territory.
9. Regulatory & safety status
- USA/EU: not FDA or EMA approved; sold as a research chemical not for human use. No established human toxicology, no controlled human trials.
- Community-reported side effects: none specific to Adamax documented in this session's extraction (no substantive review footprint found).
Images
No real product photos available. No Adamax images were captured in this session (0/8 views present in img/); vendor listing images were not verifiably captured as distinct real photos. Do not treat the absence of photos as a data point about the compound.
Not medical advice. This is community research, not a recommendation. Adamax is an unapproved research chemical with no human safety data; it is not for human use. Talk to a clinician before considering any peptide.
Named sources
- YouTube — a personal-comparison video (linked below) claimed longer duration, consistency, focus, and clarity than Semax — one creator's account, not evidence.
- TikTok — search snippets show Semax-vs-Adamax discussion, i.e., the compound is known in short-form creator circles.
- YouTube creator content (personal comparison video) — proves at least one self-experimenter bought and compared it against Semax and reported longer duration/consistency.
- TikTok search snippets (Semax-vs-Adamax discussion) — proves the compound is discussed in short-form creator culture.
Source URLs were not recorded for these references.